Drug profile · INN
apomorphine hydrochloride
APOMORPHINE HYDROCHLORIDE
apomorphine hydrochloride (APOMORPHINE HYDROCHLORIDE) is a d2-like dopamine receptor agonist. Route of administration: subcutaneous. Current US regulatory status: approved.
Drug details — apomorphine hydrochloride
- US status
- approved
- Class
- —
- Route
- SUBCUTANEOUS
- Patents
- 1
- Programs
- 5
- Data quality
- 0.84
Quick answer
apomorphine hydrochloride (APOMORPHINE HYDROCHLORIDE) is a d2-like dopamine receptor agonist. Route of administration: subcutaneous. Current US regulatory status: approved.
Key facts
Mechanism of action
D2-like dopamine receptor agonist
Primary target: D2-like dopamine receptor
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Pipeline programs
Related & competitor drugs
Related patents
Frequently asked questions
What is apomorphine hydrochloride?
apomorphine hydrochloride (APOMORPHINE HYDROCHLORIDE) is a d2-like dopamine receptor agonist. Route of administration: subcutaneous. Current US regulatory status: approved.
What is the brand name for apomorphine hydrochloride?
APOMORPHINE HYDROCHLORIDE is a marketed brand name for apomorphine hydrochloride. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of apomorphine hydrochloride?
apomorphine hydrochloride has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.